A Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study

NCT05777993 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Pyruvate Kinase Deficiency
Anemia, Hemolytic

Interventions

DRUG: Mitapivat

Sponsor

Agios Pharmaceuticals, Inc.